Xwell (XWEL) Revenue Growth (1y) (2011 - 2026)
Xwell (XWEL) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.49% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 5.54% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 9.66% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 38.82% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 9.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 4.48% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.21% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | -5.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.48% |
| Dec 31, 2025 | -4.19% |
| Sep 30, 2025 | -12.79% |
| Jun 30, 2025 | -17.16% |
| Mar 31, 2025 | -19.52% |
| Dec 31, 2024 | 0.86% |
| Sep 30, 2024 | 12.77% |
| Jun 30, 2024 | 13.54% |
| Mar 31, 2024 | 23.55% |
| Dec 31, 2023 | -2.05% |
| Sep 30, 2023 | -30.44% |
| Jun 30, 2023 | -39.88% |
| Mar 31, 2023 | -70.63% |
| Dec 31, 2022 | -85.09% |
| Sep 30, 2022 | -59.89% |
| Jun 30, 2022 | 49.55% |
| Mar 31, 2022 | 182.52% |
| Dec 31, 2021 | 15,593.19% |
| Sep 30, 2021 | 13,216.92% |
| Jun 30, 2021 | 6,258.04% |